Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Neoplasms 2Stomach Neoplasms 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma (PDAC) 1Ovarian Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1

Interventions

Gemcitabine 53Bevacizumab 52Cyclophosphamide 49Docetaxel 42Carboplatin 40pembrolizumab 37Paclitaxel 36Fluorouracil 36Cisplatin 35Radiotherapy 31Oxaliplatin 31Capecitabine 29Irinotecan 28Dexamethasone 27Leucovorin 25Cetuximab 25Nivolumab 24Doxorubicin 22Drug Therapy 21Erlotinib Hydrochloride 20Pemetrexed 19durvalumab 18trametinib 17fludarabine 16atezolizumab 16Trastuzumab 16Sunitinib 16Rituximab 16Prednisone 16Sorafenib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms × FAPI-46 × Clear all
NCT05903807 2026-05-27

[68Ga]Ga-FAPI-46 PET/CT in Ovarian Cancer

Aalborg University Hospital

Phase 2 Terminated
20 enrolled
Gynecologic

Neoplasms, Ovarian Neoplasms

NCT05898854 2025-12-30

[68Ga]Ga-FAPI PET/CT in Gastric and Gastroesophageal Junctional Cancer

Aalborg University Hospital

Phase 2 Completed
20 enrolled
Gastrointestinal

Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡